ARCHIVES

Letters To the Editor: Blumenthal Coverage Called “Destructive”

This article is from The Cancer Letter archive.

Vol. 23 No. 44 | November 14, 1997

Download PDF Visit The Full Archive

Related Articles

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

NCI’s Robert Wittes Named Physician-In-Chief, Memorial Sloan-Kettering Cancer Center.

December 7, 2001

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001